BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 19493592)

  • 1. Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase.
    Girisha HR; Narendra Sharath Chandra JN; Boppana S; Malviya M; Sadashiva CT; Rangappa KS
    Eur J Med Chem; 2009 Oct; 44(10):4057-62. PubMed ID: 19493592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.
    da Silva CH; Campo VL; Carvalho I; Taft CA
    J Mol Graph Model; 2006 Oct; 25(2):169-75. PubMed ID: 16413803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models.
    Chandra JN; Malviya M; Sadashiva CT; Subhash MN; Rangappa KS
    Neurochem Int; 2008 Feb; 52(3):376-83. PubMed ID: 17719699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS-selective noncompetitive cholinesterase inhibitors derived from the natural piperidine alkaloid (-)-spectaline.
    Castro NG; Costa RS; Pimentel LS; Danuello A; Romeiro NC; Viegas C; Barreiro EJ; Fraga CA; Bolzani VS; Rocha MS
    Eur J Pharmacol; 2008 Feb; 580(3):339-49. PubMed ID: 18096154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tacrine-based dual binding site acetylcholinesterase inhibitors as potential disease-modifying anti-Alzheimer drug candidates.
    Camps P; Formosa X; Galdeano C; Gómez T; Muñoz-Torrero D; Ramírez L; Viayna E; Gómez E; Isambert N; Lavilla R; Badia A; Clos MV; Bartolini M; Mancini F; Andrisano V; Bidon-Chanal A; Huertas O; Dafni T; Luque FJ
    Chem Biol Interact; 2010 Sep; 187(1-3):411-5. PubMed ID: 20167211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel 2,6-disubstituted pyridazinone derivatives as acetylcholinesterase inhibitors.
    Xing W; Fu Y; Shi Z; Lu D; Zhang H; Hu Y
    Eur J Med Chem; 2013 May; 63():95-103. PubMed ID: 23466605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and efficacy of 1-[bis(4-fluorophenyl)-methyl]piperazine derivatives for acetylcholinesterase inhibition, as a stimulant of central cholinergic neurotransmission in Alzheimer's disease.
    Sadashiva CT; Narendra Sharath Chandra JN; Ponnappa KC; Veerabasappa Gowda T; Rangappa KS
    Bioorg Med Chem Lett; 2006 Aug; 16(15):3932-6. PubMed ID: 16735118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
    Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
    Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New selective acetylcholinesterase inhibitors designed from natural piperidine alkaloids.
    Viegas C; Bolzani VS; Pimentel LS; Castro NG; Cabral RF; Costa RS; Floyd C; Rocha MS; Young MC; Barreiro EJ; Fraga CA
    Bioorg Med Chem; 2005 Jul; 13(13):4184-90. PubMed ID: 15878668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of novel N-aryl sulfonamide substituted 3-morpholino arecoline derivatives as muscarinic receptor 1 agonists in Alzheimer's dementia models.
    Kumar YC; Malviya M; Chandra JN; Sadashiva CT; Kumar CS; Prasad SB; Prasanna DS; Subhash MN; Rangappa KS
    Bioorg Med Chem; 2008 May; 16(9):5157-63. PubMed ID: 18359231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease.
    Anand P; Singh B; Singh N
    Bioorg Med Chem; 2012 Feb; 20(3):1175-80. PubMed ID: 22257528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease.
    Arce MP; Rodríguez-Franco MI; González-Muñoz GC; Pérez C; López B; Villarroya M; López MG; García AG; Conde S
    J Med Chem; 2009 Nov; 52(22):7249-57. PubMed ID: 19856923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfonamides as multifunctional agents for Alzheimer's disease.
    Bag S; Tulsan R; Sood A; Cho H; Redjeb H; Zhou W; LeVine H; Török B; Török M
    Bioorg Med Chem Lett; 2015 Feb; 25(3):626-30. PubMed ID: 25537270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative molecular field analysis study of N-benzylpiperidines as acetylcholinesterase inhibitors.
    Tong W; Collantes ER; Chen Y; Welsh WJ
    J Med Chem; 1996 Jan; 39(2):380-7. PubMed ID: 8558505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of novel 4-[(3H,3aH,6aH)-3-phenyl)-4,6-dioxo-2-phenyldihydro-2H-pyrrolo[3,4-d]isoxazol-5(3H,6H,6aH)-yl]benzoic acid derivatives as potent acetylcholinesterase inhibitors and anti-amnestic agents.
    Anand P; Singh B
    Bioorg Med Chem; 2012 Jan; 20(1):521-30. PubMed ID: 22172310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
    Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
    J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors.
    Huang L; Shi A; He F; Li X
    Bioorg Med Chem; 2010 Feb; 18(3):1244-51. PubMed ID: 20056426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new approach in development of anti-Alzheimer's disease drugs via the cholinergic hypothesis.
    Sugimoto H
    Chem Biol Interact; 2008 Sep; 175(1-3):204-8. PubMed ID: 18577377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminopyridazines as acetylcholinesterase inhibitors.
    Contreras JM; Rival YM; Chayer S; Bourguignon JJ; Wermuth CG
    J Med Chem; 1999 Feb; 42(4):730-41. PubMed ID: 10052979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.